Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novo Nordisk notches another phase 3 success for GLP-1 drug
Novo Nordisk notches another phase 3 success for GLP-1 drug
Novo Nordisk notches another phase 3 success for GLP-1 drug
Submitted by
admin
on February 26, 2016 - 10:18am
Source:
BioPharma Dive
News Tags:
Novo Nordisk
diabetes
GLP-1 agonist
semaglutide
Headline:
Novo Nordisk notches another phase 3 success for GLP-1 drug
Do Not Allow Advertisers to Use My Personal information
